Skystar Q1 revenues up 46%
Skystar has reported a net income of $1.93m, or $0.27 per diluted share, compared to net income of $1.1m or $0.15 per diluted share, for the same period
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.